Focus Partners Wealth’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$156K Sell
11,487
-31,504
-73% -$377K ﹤0.01% 2560
2026
Q1
$258K Sell
42,991
-11,430
-21% -$86K ﹤0.01% 2275
2025
Q4
$391K Buy
54,421
+7,403
+16% +$58.5K ﹤0.01% 2066
2025
Q3
$502K Sell
47,018
-9,823
-17% -$96.4K ﹤0.01% 1612
2025
Q2
$550K Buy
56,841
+966
+2% +$9.96K ﹤0.01% 1400
2025
Q1
$832K Buy
55,875
+13,875
+33% +$213K ﹤0.01% 1129
2024
Q4
$627K Buy
+42,000
New +$684K ﹤0.01% 1225

Other funds holding OGN

Focus Partners Wealth's OGN Position: Q2 2026 in Review

Focus Partners Wealth reduced its Organon & Co (OGN) stake by 73% in Q2 2026, selling an estimated $377K and leaving 11,487 shares worth $156K. The position accounts for ﹤0.01% of the portfolio, ranked #2560.

Focus Partners Wealth first reported a position in OGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $832K in Q1 2025. 627 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Focus Partners Wealth held 11,487 shares of Organon & Co worth $156K as of Q2 2026.
  • Focus Partners Wealth sold 31,504 Organon & Co shares in Q2 2026, an estimated $377K.
  • Organon & Co made up ﹤0.01% of Focus Partners Wealth's portfolio in Q2 2026, its #2560 holding.
  • Focus Partners Wealth first reported a position in Organon & Co in Q4 2024 and has held it in 7 quarters since.
  • Focus Partners Wealth's Organon & Co position peaked at $832K in Q1 2025.
  • 627 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.